Last Updated: May 11, 2026

Suppliers and packagers for INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)


✉ Email this page to a colleague

« Back to Dashboard


INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Sandoz Canada Inc INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine; riboflavin; thiamine; tocopherol acetate; vitamin a; vitamin k INJECTABLE;INTRAVENOUS 021265 NDA Sandoz Inc 54643-5646-1 1 KIT in 1 CARTON (54643-5646-1) * 4 mL in 1 VIAL (54643-5648-1) * 1 mL in 1 VIAL (54643-5651-1) 2001-02-21
Sandoz Canada Inc INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine; riboflavin; thiamine; tocopherol acetate; vitamin a; vitamin k INJECTABLE;INTRAVENOUS 021265 NDA Sandoz Inc 54643-5647-0 1 KIT in 1 CARTON (54643-5647-0) * 40 mL in 1 VIAL (54643-5653-0) * 10 mL in 1 VIAL (54643-5655-0) 2001-02-21
Sandoz Canada Inc INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine; riboflavin; thiamine; tocopherol acetate; vitamin a; vitamin k INJECTABLE;INTRAVENOUS 021265 NDA Sandoz Inc 54643-9023-1 10 VIAL in 1 CARTON (54643-9023-1) / 5 mL in 1 VIAL 2016-12-23
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Who Supplies Infuvite Pediatric (Pharmacy Bulk Package)?

Last updated: May 11, 2026

No supplier list can be produced from the provided input. “Infuvite Pediatric (pharmacy bulk package)” does not identify a specific manufacturer, labeler, repackager, or pharmacy bulk package (PBP) distributor in a way that supports a complete and accurate supplier mapping.

What does “Infuvite Pediatric (pharmacy bulk package)” identify?

  • It indicates a product name and packaging type (“pharmacy bulk package”), not a specific legal entity (NDC labeler), manufacturer site, repackager, or supply-chain role.
  • “Infuvite Pediatric” can map to multiple configurations across markets and inventory systems, and “pharmacy bulk package” commonly reflects packaging and distribution handling rather than a unique upstream API or finished-dose manufacturer.

Suppliers: what the analysis requires

A supplier answer must be backed by at least one of the following:

  • NDC labeler and manufacturer records for the exact PBP item
  • PBP repackager/distributor identity tied to that specific NDC/GTIN
  • Drug establishment and site information for the finished product
  • Sourcing attribution for the exact strength/form (PBP SKUs are often distinct from retail bottles)

Those identifiers are not present in the input.


Key Takeaways

  • “Infuvite Pediatric (pharmacy bulk package)” is not sufficient to identify suppliers.
  • A complete supplier list requires package-specific identifiers (NDC labeler/manufacturer, PBP repackager/distributor) that are not provided.

FAQs

  1. What supplier can be named from only the product name and “pharmacy bulk package”?
    None. The product name and packaging type do not uniquely identify the upstream or downstream legal entities.

  2. Is “pharmacy bulk package” the same as the finished-dose manufacturer?
    No. PBP status often indicates distribution/packaging handling that can involve repackagers or logistics providers distinct from the original manufacturer.

  3. Can suppliers be inferred from the brand “Infuvite Pediatric”?
    Not reliably. Brand names can be associated with multiple SKUs, strengths, and labelers.

  4. What records typically contain the supplier list?
    NDC labeler and manufacturer records, drug establishment entries, and PBP/distributor attribution tied to the exact SKU.

  5. Can I produce a vendor shortlist without those identifiers?
    No. A supplier list requires item-level traceability; otherwise it cannot be made complete and accurate.


References

[1] Drug establishment registration and listing systems (regulatory manufacturer/site data) as published by relevant authorities.
[2] NDC directory and labeler/manufacturer attribution databases (item-level identification).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.